Lv3
226 积分 2023-07-14 加入
Precision medicine in pancreatic cancer: Patient derived organoid pharmacotyping is a predictive biomarker of clinical treatment response
6天前
已完结
Molecular subtypes of pancreatic cancer
6天前
已完结
Moving the Needle on Precision Medicine in Pancreatic Cancer
6天前
已完结
Precision medicine in pancreatic cancer: treating every patient as an exception
6天前
已完结
Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed
6天前
已完结
Pancreatic cancer evolution and heterogeneity: integrating omics and clinical data
7天前
已完结
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
7天前
已完结
Therapeutic developments in pancreatic cancer
7天前
已完结
Advances in the management of pancreatic cancer
8天前
已完结
A generative AI framework unifies human multi-omics to model aging, metabolic health, and intervention response
17天前
已完结
皖公网安备34019202002308
